MYELOPROLIFERATIVE DISORDER
Clinical trials for MYELOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers: optimized transplant trial seeks to control disease
Disease control Recruiting nowThis study is collecting information on patient outcomes after receiving a cord blood transplant using Memorial Sloan Kettering's optimized procedure. It aims to see how well this standard transplant approach works for adults with high-risk blood cancers like leukemia, lymphoma, …
Matched conditions: MYELOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Massive 5,000-Person study launches to map the journey of rare blood cancers
Knowledge-focused Recruiting nowThis is a long-term observational study aiming to better understand a group of rare, chronic blood cancers called myeloproliferative neoplasms (MPNs). It will follow 5,000 adults in the U.S. who have been diagnosed with an MPN for at least five years, collecting information from …
Matched conditions: MYELOPROLIFERATIVE DISORDER
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC